Radiolabeled Nanoparticles for Cancer Diagnosis and Therapy

Author(s): Jacek Koziorowski, Adina E. Stanciu, Vanessa Gomez-Vallejo, Jordi Llop

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 17 , Issue 3 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Cancer remains as one of the major causes of death worldwide. The emergence of nanotechnology has opened new avenues for the development of nanoparticle (NP)- based diagnostic and therapeutic tools. NPs of different chemical composition, size, shape and surface decoration can be prepared using a wide variety of synthetic strategies. Subsequent radiolabelling with positron or gamma emitters results in potential diagnostic agents which may offer improved selectivity and/or specificity for the target organ or tissue, enabling the acquisition of images with higher signal-to-contrast ratio. Incorporation of alpha or beta emitters leads to therapeutic agents with application in the field of radiotherapy. Here, we first describe the different labeling strategies reported so far for the incorporation of radionuclides into NPs. Recent advances in the use of nanoparticulate constructs both in the diagnostic and therapeutic arenas are then discussed and examples of their application are briefly discussed.

Keywords: Radiolabelling, cancer diagnosis, therapy, radiometal, nanoparticles.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 19 February, 2017
Page: [333 - 354]
Pages: 22
DOI: 10.2174/1871520616666160219162902
Price: $65

Article Metrics

PDF: 56
HTML: 11